CCLD Stock Analysis: Buy, Sell, or Hold?
CCLD - CareCloud, Inc. Common Stock
$2.36
-0.11 (-4.45%)
▼
5d:
-21.07%
30d:
-14.49%
90d:
-3.67%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When CCLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CCLD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CCLD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CCLD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.67
Based on -7.2% avg growth
INTRINSIC VALUE TODAY
$1.66
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CCLD is currently trading at $2.36, which is considered oversold relative to its 30-day fair value range of $2.77 to $3.34. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.7) compared to its historical average (12.9). Remarkably, the market is currently pricing in an annual earnings decline of 15.7% over the next few years. This pessimistic expectation contrasts with the company's recent 5739.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.25, while resistance sits at $3.28. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: CCLD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.31 (+167.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.25, while resistance sits at $3.28. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: CCLD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.31 (+167.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.77 -
$3.34
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.5%)
- BULLISH: Trading 167.5% below Wall St target ($6.31)
- CAUTION: 5-day price weakness (-21.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.77 -
$3.34
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.25
Resistance Level
$3.28
Current Trend
Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.74
Wall Street Target
$6.31
(+167.5%)
Revenue Growth (YoY)
21.9%
Earnings Growth (YoY)
5739.0%
Profit Margin
9.0%
Valuation Discount vs History
-15.7% cheaper
PE vs Historical
7.7 vs 12.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-15.7%
(market-implied from PE analysis)
1-Year Target
$2.12
(-10%)
2-Year Target
$1.91
(-19%)
3-Year Target
$1.72
(-27%)
3-Yr Target (if PE normalizes)
(PE: 8→13)
$2.87
(+22%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: -18.3%)
$4.88
(+107%)
Base:
(SPY PE: 7.7, Growth: -18.3%)
$1.72
(-27%)
Bear:
(PE: 6.6, Growth: -18.3%)
$1.46
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 19.00 | Current EPS (TTM): $0.13
Bull Case
$5.43
(+130%)
Analyst growth 100.0%, PE expands to 20.9
Base Case
$4.94
(+109%)
Market implied 100.0%, PE stable at 19.0
Bear Case
$1.68
(-29%)
Severe decline -20.0%, PE contracts to 16.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.7 to 12.9
Stabilization Target:
$3.93
(+66.7%)
PE Expansion Potential:
+66.7%
Share & Embed Analysis
Last updated: May 08, 2026 10:45 PM ET
Data refreshes hourly during market hours. Next update: 11:45 PM
Data refreshes hourly during market hours. Next update: 11:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
John N Daly
SELL
15000 shares
2025-11-10
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$264 | 59 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 52 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$16 | 57 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$5 | 62 BUY |
